Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Dana Elkhalifa, Feras Alali, Ala-Eddin Al Moustafa & Ashraf Khalil. (2019) Targeting triple negative breast cancer heterogeneity with chalcones: a molecular insight. Journal of Drug Targeting 27:8, pages 830-838.
Read now
Read now
Articles from other publishers (19)
Fan Wang, Rong Liao, Xin Wang, Guixiang Xiong, Beibei Zhang, Juan Li, Dengpan Wu, Yan Chen, Xueyan Zhou, Xiaoke Gu, Qi Qi & Chenglin Li. (2023) N-3, a novel synthetic derivative of bifendate, inhibits metastasis of triple-negative breast cancer via decreasing p38-regulated FOXC1 protein stability. Biochemical Pharmacology 215, pages 115729.
Crossref
Crossref
Agnes Bocian-Jastrzębska, Anna Malczewska-Herman & Beata Kos-Kudła. (2023) Role of Leptin and Adiponectin in Carcinogenesis. Cancers 15:17, pages 4250.
Crossref
Crossref
Jiawei Zhang, Qun Zeng & Meihua She. (2023) The roles of FHL2 in cancer. Clinical and Experimental Medicine 23:7, pages 3113-3124.
Crossref
Crossref
Na Li, Ling Xu, Ji Zhang & Yongyu Liu. (2022) High level of FHL2 exacerbates the outcome of non‐small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells. International Journal of Experimental Pathology 103:3, pages 90-101.
Crossref
Crossref
Wei-Chieh Huang, Jia-Hau Yen, Yu-Wen Sung, Shiao-Lin Tung, Po-Ming Chen, Pei-Yi Chu, Ya-Chi Shih, Hsiang-Cheng Chi, Yi-Ching Huang, Shih-Jei Huang & Lu‐Hai Wang. (2022) Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET. Oncogene 41:7, pages 997-1010.
Crossref
Crossref
Yi-Hsuan Huang, Sung-How Sue, Zih-Syuan Wu, Shih-Ming Huang, Shih-Yu Lee & Zhi-Fu Wu. (2022) Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells. Frontiers in Oncology 12.
Crossref
Crossref
Ishita Gupta, Ayesha Jabeen, Semir Vranic, Ala-Eddin Al Moustafa & Hamda Al-Thawadi. (2021) Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways. Frontiers in Oncology 11.
Crossref
Crossref
Nilesh Malavia, Kaushik Kuche, Rohan Ghadi & Sanyog Jain. (2021) A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer. Journal of Controlled Release 330, pages 72-100.
Crossref
Crossref
Alejandra Zevallos, Leny Bravo, Denisse Bretel, Kevin Paez, Ulises Infante, Nadezhda Cárdenas, Hober Alvarado, Ana M. Posada & Joseph A. Pinto. (2020) The hispanic landscape of triple negative breast cancer. Critical Reviews in Oncology/Hematology 155, pages 103094.
Crossref
Crossref
Margarite D. Matossian, Hope E. Burks, Steven Elliott, Van T. Hoang, William J. Zuercher, Carrow Wells, David H. Drewry, Nirav Kapadia, Tiffany Chang, Thomas Yan, Gabrielle O. Windsor, Khoa Nguyen, Fang Fang, Kenneth P. Nephew, Aaron Buechlein, Douglas B. Rusch, Rachel A. Sabol, Deniz A. Ucar, Jovanny Zabaleta, Lucio Miele, Bruce A. Bunnell, Bridgette M. Collins-Burow & Matthew E. Burow. (2020) A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways. Anti-Cancer Drugs 31:8, pages 759-775.
Crossref
Crossref
Kai Miao, Josh Haipeng Lei, Monica Vishnu Valecha, Aiping Zhang, Jun Xu, Lijian Wang, Xueying Lyu, Si Chen, Zhengqiang Miao, Xin Zhang, Sek Man Su, Fangyuan Shao, Barani Kumar Rajendran, Jiaolin Bao, Jianming Zeng, Heng Sun, Ping Chen, Kaeling Tan, Qiang Chen, Koon Ho Wong, Xiaoling Xu & Chu-Xia Deng. (2020) NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation. Nature Communications 11:1.
Crossref
Crossref
Li Tang, Yuli Chen, Huanhuan Chen, Pan Jiang, Linping Yan, Dongping Mo, Xun Tang & Feng Yan. (2020) DCST1-AS1 Promotes TGF-β-Induced Epithelial–Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1. Frontiers in Oncology 10.
Crossref
Crossref
Sapana Sameer Chaudhary, Sameer Choudhary, Sakshi Rawat, Gouri Ahir, Anwar L. Bilgrami & Ghulam Md Ashraf. 2020. Cancer-Leading Proteases. Cancer-Leading Proteases
295
326
.
Ishita Gupta, Rasha Sareyeldin, Israa Al-Hashimi, Hamda A. Al-Thawadi, Halema Al Farsi, Semir Vranic & Ala-Eddin Al Moustafa. (2019) Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity. Cancers 11:3, pages 363.
Crossref
Crossref
Su Yeon Lee, Min Kyung Ju, Hyun Min Jeon, Yig Ji Lee, Cho Hee Kim, Hye Gyeong Park, Song Iy Han & Ho Sung Kang. (2018) Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype. Oxidative Medicine and Cellular Longevity 2018, pages 1-28.
Crossref
Crossref
Jiasheng Wu, Yueyue Weng, Fei He, Dong Liang & Lin Cai. (2018) LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer. Anti-Cancer Drugs 29:7, pages 628-636.
Crossref
Crossref
Shaimaa Elzamly, Nabeel Badri, Osvaldo Padilla, Alok Kumar Dwivedi, Luis A Alvarado, Matthew Hamilton, Nabih Diab, Crosby Rock, Ahmed Elfar, Marwa Teleb, Luis Sanchez & Zeina Nahleh. (2018) Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy. Breast Cancer: Basic and Clinical Research 12, pages 117822341878807.
Crossref
Crossref
Zhuo-Jia Chen, Wei Wei, Guan-Min Jiang, Hao Liu, Wei-Dong Wei, Xiangling Yang, Ying-Min Wu, Huanliang Liu, Chris K.C. Wong, Jun Du & Hong-Sheng Wang. (2016) Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals. Molecular Oncology 10:6, pages 775-788.
Crossref
Crossref
Katherine Chang, Anand Karnad, Shujie Zhao & James W. Freeman. (2015) Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets. Oncotarget 6:6, pages 3507-3518.
Crossref
Crossref